You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

post-polycythemia vera/essential thrombocythemia-MF (secondary MF)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Acute Myeloid Leukemia, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Farmington Hills, Sterling Heights

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Farmington Hills, Michigan
  • +1 more
Jun 5, 2021

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis

Terminated
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Larkspur, California
  • +2 more
Nov 14, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Feb 10, 2022

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

Recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Ruttenberg Treatment Center
Jul 18, 2022

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Primary Myelofibrosis Trial in Japan (Fedratinib)

Recruiting
  • Primary Myelofibrosis
  • Suwa, Nagano, Japan
  • +25 more
Jan 18, 2023

Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Worcester, Massachusetts
  • +16 more
Oct 31, 2022

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)

    Recruiting
    • Myelofibrosis Due to and Following Polycythemia Vera
    • Basking Ridge, New Jersey
    • +6 more
    Jan 26, 2023

    Myelofibrosis Trial in Worldwide (Ruxolitinib)

    Completed
    Has Results
    • Myelofibrosis
    • Winter Park, Florida
    • +17 more
    Jan 10, 2022

    Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

    Available
    • Primary Myelofibrosis (PMF)
    • +2 more
    • (no location specified)
    Jan 18, 2022

    Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablet
    • Canton, Ohio
      Site 01
    Aug 18, 2022

    Myelofibrosis Trial in Worldwide (PXS-5505)

    Recruiting
    • Myelofibrosis
    • Birmingham, Alabama
    • +19 more
    Nov 28, 2022

    Myelofibrosis, Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF) Trial in

    Completed
    • Myelofibrosis
    • +3 more
    • Ann Arbor, Michigan
    • +4 more
    Mar 28, 2022

    Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

    Recruiting
    • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Idiopathic Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia-Vera Myelofibrosis Trial in Worldwide

    Completed
    • Idiopathic Myelofibrosis
    • +2 more
    • Paris, France
    • +9 more
    Jun 22, 2021

    Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,

    Completed
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Phoenix, Arizona
    • +22 more
    Dec 7, 2021

    Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

    Active, not recruiting
    • Myelofibrosis
    • +2 more
    • New Orleans, Louisiana
    • +20 more
    Aug 25, 2022

    Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

    Recruiting
    • Myelofibrosis; Anemia
    • +5 more
    • Jacksonville, Florida
    • +6 more
    Jan 3, 2023

    Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Post-Essential Thrombocythemia Myelofibrosis

    Recruiting
    • Primary Myelofibrosis (PMF)
    • +2 more
    • Glendale, California
    • +28 more
    May 5, 2022

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022